Tri-Wedge PTA Scoring Balloon in AVF & Lower Extremity Intervention
Release time:
2022-10-19
BrosMed Medical sincerely invites you to attend our coming webinar “Tri-Wedge PTA Scoring Balloon in AVF & Lower Extremity Intervention” on Wednesday Oct. 19th, 2022 at 07:00-08:00am (CEST, UTC +2) or 13:00-14:00pm (MYT, UTC +8).
BrosMed Medical sincerely invites you to attend our coming webinar “Tri-Wedge PTA Scoring Balloon in AVF & Lower Extremity Intervention” on Wednesday Oct. 19th, 2022 at 07:00-08:00am (CEST, UTC +2) or 13:00-14:00pm (MYT, UTC +8).
Tri-Wedge™ PTA Scoring balloon dilatation catheter is an ideal tool for AV Fistula Stenosis and Lower Extremity Intervention with special design of three Triangular metallic wires 360° for precise and effective dilatation.
Join the session with our distinguished vascular experts for up-close interaction and to explore more on the clinical significance of Tri-Wedge™ PTA Scoring balloon dilatation catheter.
Honored Guest Speakers:
Dr. Ahmad Rafizi Hariz Ramli, Senior Lecturer in the Department of Surgery in the University of Malaya; Consultant Vascular and Endovascular Surgeon of University Malaya Medical Centre (UMMC).
Dr. Robert Shahverdyan, Vascular and Endovascular Surgeon, Head of Vascular (Dialysis) Access Center at the Asklepios Clinic Barmbek in Hamburg, Germany.
If you are interested in attending the webinar, please scan the QR code on the poster or click the Link to register and join with us and watch the live broadcast.
Previous Article
Next Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
